Owlet, Inc.
Close on Oct 19, 2026
- Market cap
- $118.62M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 12, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 11, 2026 | After market close | $33.90M | $-0.05 | $0.20 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $22.50M | $-0.25 | $-0.09 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 5, 2026 | After market close | $26.60M | $-0.39 | $-0.03 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 13, 2025 | After market close | $32.00M | $-0.06 | $0.03 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | After market close | $26.10M | $-2.37 | $-0.05 |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $21.10M | $0.11 | $-0.07 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 4, 2025 | After market close | $20.50M | $-0.63 | $-0.07 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 13, 2024 | After market close | $22.10M | $-0.61 | $0.03 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 12, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 6, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 7, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 11, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full year 2026 | $10.75M to $12.75M | Raised |
| Gross Margin | full year 2026 | 53% to 55% | Raised |
| Total Revenue | full year 2026 | $118.00M to $122.00M | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Owlet filed with the SEC
Owlet Announces Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces First Quarter 2026 Financial Results; Updates 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
Owlet Reports Fourth Quarter and Full Year 2025 Results; Initiates 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
IN THE UNITED STATES DISTRICT COURT
Other events · EX-99.1 to Form 8-K
Owlet Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
Case 2:24-cv-07258-FLA-PVC Document 32-3 Filed 04/09/25 Page 28 of 69 Page ID #:334
Other events · EX-99.2 to Form 8-K
Owlet Reports Second Quarter 2025 Financial Results;
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Owlet Announces First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Fourth Quarter and Full Year 2024 Results
Results of operations · EX-99 to Form 8-K
Owlet Announces Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Strong Second Quarter 2024 Results, Achieves Record-Breaking Amazon Prime Day
Results of operations · EX-99.1 to Form 8-K
Owlet Announces CFO Transition and Re-Affirms 2024 Financial Goals
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Announces Strong First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Fourth Quarter and Fiscal Year 2023 Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces $9 Million Private Placement Financing
Material agreement · Results of operations · Unregistered share sale · Charter or bylaw amendment · Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Announces Strong Preliminary Fourth Quarter 2023 Results and to Report Fourth Quarter 2023 Financial Results on March 7, 2024
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Achieves De Novo FDA-Clearance For Dream Sock® – The First and Only Over-the-Counter, Medical Grade Pulse Oximeter Cleared for Infants
Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet, Inc. Announces NYSE Acceptance of
Regulation FD disclosure · EX-99.1 to Form 8-K
1-FOR-14 REVERSE STOCK SPLIT WILL BECOME EFFECTIVE
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Owlet Announces First Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Receives Notice Regarding NYSE Continued Listing Standards
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Announces Fourth Quarter and Fiscal Year 2022 Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces $30 Million Private Placement Financing
Material agreement · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Announces FDA Software-as-a-Medical Device Submission
Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Receives Notice Regarding NYSE Continued Listing Standards
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Owlet Announces Third Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Reports Preliminary Third Quarter 2022 Net Revenue Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Second Quarter 2022 Financial Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Owlet Announces First Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Fourth Quarter and Fiscal Year 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K
Owlet Announces Third Quarter 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K